Industries > Pharma > Global Pharma Contract Sales Market 2019-2029

Global Pharma Contract Sales Market 2019-2029

Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services, Cardiovascular Disease, Metabolic Disorders, Oncology

PUBLISHED: 28 February 2019
PAGES: 253
PRODUCT CODE: PHA0357
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0357 Categories: , Tag:

The global pharma contract sales market is expected to grow at a CAGR of 8.9% in the first half of the forecast period. In 2018, the contract detailing segment held 76% of the global pharma contract sales market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 253-page report you will receive 104 tables and 67 figures– all unavailable elsewhere.

The 253-page report provides clear detailed insight into the global pharma contract sales market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pharma Contract Sales Market forecasts from 2019-2029

• Along with revenue prediction for the overall world market for pharma contract sales market, our investigation shows forecasts to 2029 for the following submarket by leading services:
• Contract detailing (personal promotion/field sales)
• Contract non-personal promotion, with further sub-forecasting for teledetailing, eDetailing and others
• Medical education services
• Sample management services

• This report also breaks down the revenue forecast for pharma contract sales market by therapeutic segments:
• Cardiovascular disease
• Metabolic disorders
• Oncology
• Other

• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• US
• Japan
• EU5: Germany, UK, France, Italy and Spain
• BRIC: China, India, Brazil and Russia

The US, Japan, EU5 and BRIC markets are further segmented by therapeutic segments and leading services

Global Pharma Contract Sales Market 2019-2029

• Our study discusses the SWOT and STEP factors of the global pharma contract sales market

• Our study also discusses factors that will drive and restrain the global pharma contract sales market

• Our study discusses issues affecting the pharma contract sales industry and market:
• Outsourced and in-house sales reps – trends and emerging sales models, including multiple channels (multichannel marketing to medical professionals)
Services CSOs offer and benefits to drug companies outsourcing medical sales
• Maturing brands and product launches, including flexibility in field sales teams
Legislation and new market access requirements for pharma sales representatives
• Changes to online marketing and potential for IT technologies Risk-sharing agreements
Key account management (KAM) and medical science liaison (MSL)

• This report discusses the leading companies in pharma contract sales:
• CMIC
• IQVIA
• Marvecs
• OnCall, LLC
• Publicis Healthcare Communications Group (PHCG)
• Sofip
• Syneos Health (INC Research and inVentiv Health
• UDG Healthcare

Visiongain’s study is intended for anyone requiring commercial analyses for the global pharma contract sales market. You find data, trends and predictions.

Buy our report today Global Pharma Contract Sales Market 2019-2029: Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services, Cardiovascular Disease, Metabolic Disorders, Oncology.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Pharma Contract Sales Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Global Pharma Contract Sales Market 2019-2029


Latest Pharma news

“Biological Drug API Manufacturing market set to grow to $11bn by 2025” says Visiongain report

Strengths in the biotech contract manufacturing market, from the perspective of the CMOs, stem from the demand for lower cost manufacturing from companies of all sizes.

07 November 2019

READ

“global radiation oncology market is anticipated to surpass USD 6.5 billion by 2020”, says Visiongain

Growing aging population, urbanization, and growing wealth in low- and middle-income countries such as China and India are anticipated to boost the APAC radiation oncology market.

07 November 2019

READ

“Global Rabies Diagnostics Market is anticipated to surpass USD 1.8 billion by 2020”, says Visiongain

Several international healthcare organizations are working with healthcare organizations to develop and market new detection assays to drive efforts aimed at fighting the disease.

07 November 2019

READ

“Global spinal muscular atrophy (SMA) market is anticipated is to surpass USD 950 Million by 2020”, says Visiongain

Increasing awareness of SMA and increasing numbers of programs to expand treatment options for rare diseases are key factors that are boosting the market growth.

07 November 2019

READ

Categories

Category